Miglustat: A Viewpoint by Ernest Beutler

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.22, 2003-01, pp. : 2435-2436

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Miglustat

By McCormack P.L. Goa K.L.

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2427-2434

Adis International

Access to resources Recommend Favorite

Miglustat: Diarrhoea: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1423, 2012-01 ,pp. : 36-36

Adis International

Access to resources Recommend Favorite

Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1

By Pastores Gregory M Barnett Natalie L

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 273-281

Informa Healthcare

Access to resources Recommend Favorite

Nateglinide: A Viewpoint by Riccardo Perfetti

By Perfetti R.

Drugs, Vol. 60, Iss. 3, 2000-09 ,pp. : 616-617

Adis International

Access to resources Recommend Favorite

Tipranavir: A Viewpoint by Joel Gallant

By Gallant J.

Drugs, Vol. 63, Iss. 15, 2003-01 ,pp. : 1619-1620

Adis International

Access to resources Recommend Favorite